missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18658899

HLA-DR Antibody (37.68), Janelia Fluor™ 646, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NB100-65424JF646

Product Code. 18658899

  • € 569.00 / 125µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

HLA-DR Monoclonal antibody specifically detects HLA-DR in Human, Bovine, Goat, Sheep samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunohistochemistry (Frozen)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

HLA-DR
Monoclonal
Janelia Fluor 646
FLJ51114, histocompatibility antigen HLA-DR alpha, HLA class II histocompatibility antigen, DR alpha chain, HLA-DRA1, major histocompatibility complex, class II, DR alpha, MHC cell surface glycoprotein, MHC class II antigen DRA, MLRW
Splenocytes from ATL mice (1)
0.125 mL
Adaptive Immunity, B Cell Development and Differentiation Markers, Cell Biology, Cellular Markers, Diabetes Research, Immunology, Major Histocompatibility Complexes
3122
Store at 4°C in the dark.
IgG2a
Flow Cytometry, Immunohistochemistry, Immunohistochemistry (Frozen)
37.68
50mM Sodium Borate
Mouse
Protein G purified
RUO
Primary
Human, Bovine, Goat, Sheep
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.